Recon: European industry group voice opposition to pharma overhaul; FDA approves Sarepta’s DMD gene therapy for some children
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy